Aktiia

Executive Summary

Aktiia is a Swiss digital health company founded in 2018 that has developed a clinically validated, cuffless optical blood pressure monitor. Unlike traditional ambulatory monitors, Aktiia's wearable device enables automated 24/7 blood pressure tracking, capturing continuous data that provides a comprehensive view of a patient's cardiovascular health. The company's mission is to leverage this unique data to create programs and services that improve hypertension management and ultimately reduce cardiovascular risk. Aktiia has gained traction in Europe and is positioning itself for U.S. market entry, with its technology already included in several clinical guidelines for remote patient monitoring. The global hypertension monitoring market is large and growing, driven by an aging population and increased awareness of cardiovascular disease. Aktiia's cuffless technology offers a competitive advantage over traditional methods by providing more frequent, unobtrusive measurements, potentially leading to better patient adherence and outcomes. The company is actively pursuing regulatory clearances, scaling production, and forging partnerships with healthcare providers and payers. With its strong clinical validation and first-mover status in continuous optical blood pressure monitoring, Aktiia is well-positioned to capture a significant share of this market, though challenges remain in reimbursement and widespread clinical adoption.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for U.S. Market Entry70% success
• Q2 2026Partnership with Major U.S. Health System for Pilot Program80% success
• Q3 2026Publication of Landmark Clinical Study Demonstrating Outcomes85% success